It is our pleasure to welcome you to the 2nd World Conference on Neurology and Neurological Disorders. The Neurology Conference 2020 Special Conference builds on the hugely successful preceding conferences, hosted by the SciTech Conferences (STC). The program includes multiple opportunities for networking and interaction. As well as the lively Poster Discussion sessions, there will be Panel Discussions at the end of each day for speakers and participants to engage beyond discussing the data, into envisioning a future that integrates rapidly evolving technologies into basic, translational and clinical cancer research.
The Neurology Conference 2020 includes 40+ plenary lectures, dedicated poster sessions and interactive elements. The medium-large size of the conference makes it an excellent forum to share new data, and to network with colleagues and speakers.
Who should attend?
We welcome all Individuals representing academia, public health researchers and practitioners, Neuro researchers, Neurology-practitioners, pharmacists, psychologists, behavioral researchers, Health care professionals, social scientists, epidemiologists, social workers, students, Researchers, Academicians, Practitioners, Early Career Scholars, students along with Industries and others engaged in endeavors related to Neurology research and business, translational and clinical scientists (including postdocs and trainees), who are interested in tackling pressing Neuro-relevant questions, and who want to hear the latest developments in therapies targeting Brain, Neuro and Brain cells. We also invite industry scientists who are interested in targets for novel therapies. This is an excellent forum for informal networking and meeting potential collaborators.
Save the date
November 09 - 10, 2020. Istanbul, Turkey
(99% of participants would recommend the conference to a colleague).
NETWORK with leading International and local key opinion leaders in the field of Neurology
Meet the 100+ Experts, 15+ Workshops and Sessions, 200+ Attendees, 100+ Supporting Partners, 70+ Participating Countries, 100+ International and Regional Faculty present their Abstract/Posters/Delegates/Workshops/Special Sessions and more
Neurology Market Research Reports & Analysis
Neurology and Brain is the branch of science dealing with anatomy, function, diagnosis and treatment of disorders and disease affecting the brain and spinal cord. Neuroscience severe such as treatment of Alzheimer’s disease, major depressive disorder, schizophrenia, Parkinson’s disease, epilepsy/seizures, migraine, insomnia/sleep disorders, bipolar disorder, and ADHD is expected to fuel the demand for neurology devices thereby driving the industry.
The market for the Neurology devices is expected to witness a CAGR of around 14.3%. Here at SciTech Conferences can expect the attendee from that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Today, Pharmaceuticals research companies are developing 550 medicines for numerous, wide-ranging neurological disorders. There is hope on the horizon, as scientists are uncovering more about how the nervous system works at the molecular and genetic levels, driving the development of innovative treatments for several neurological disorders. Download the report to learn more. in Neurology and Brain are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
To attend the conference register Here to book your slots